|
Global X China Innovation ETF | KEJI | Global X MSCI China Industrials ETF | CHII | Global X AgTech & Food Innovation ETF | KROP | Amplify Thematic All-Stars ETF | MVPS | Global X Disruptive Materials ETF | DMAT | Global X Emerging Markets Great Consumer ETF | EMC | Global X S&P 500® Quality Dividend ETF | QDIV | Global X MSCI China Energy ETF | CHIE | Amplify Natural Resources Dividend Income ETF | NDIV | Global X Solar ETF | RAYS |
Gross Expense Ratio*
0.75%
SEC 30 Day Yield (as of 04/28/23 )
-0.10%
Ann. Dividend/Yield
No Regular Dividends
52-Wk Range
10.46 - 15.42
Fund Inception
02/22/2021
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to achieve long-term growth of capital.Normally, the fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in exchange-listed companies that are economically tied to China. The Sub-Adviser will seek to limit single stock exposure to 10% and limit the aggregate weight of each theme to 35%. In making these security selection determinations, the Sub-Adviser will apply its proprietary investment process, which combines (1) quantitative screens to assess areas, and (2) qualitative screens that focus on characteristics. It is non-diversified.
|
Market Return % (as of 04/30/2023) |
NAV Return % (as of 04/30/2023) |
Market Return % (as of 03/31/2023) |
NAV Return % (as of 03/31/2023) |
1-Month |
-5.46% |
-6.07% |
+1.92% |
+2.09% |
3-Month |
-14.39% |
-14.37% |
+4.28% |
+3.68% |
6-Month |
+13.77% |
+13.52% |
+13.08% |
+12.60% |
Year-to-date |
-1.41% |
-2.61% |
+4.28% |
+3.68% |
1-Year |
-6.53% |
-8.17% |
-11.28% |
-11.74% |
3-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-28.76% |
-28.71% |
-27.80% |
-27.52% |
Inception Date: February 22, 2021
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 04/30/2023) |
NAV Return % (as of 04/30/2023) |
Market Return % (as of 03/31/2023) |
NAV Return % (as of 03/31/2023) |
1-Year |
-6.53% |
-8.17% |
-11.28% |
-11.74% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-28.76% |
-28.71% |
-27.80% |
-27.52% |
Inception Date: February 22, 2021
1.88% |
27.96% |
0.00% |
32.40% |
2.56% |
0.00% |
1.17% |
0.00% |
16.16% |
14.99% |
0.00% |
7.90% |
0.00% |
27.03% |
0.00% |
51.43% |
16.50% |
Portfolio Details
|
Company |
YTD Return (as of 06/02/2023) |
% of Assets |
* BYD Co Ltd Class H |
+28.21% |
9.11% |
* Tencent Holdings Ltd |
+7.48% |
6.13% |
* Alibaba Group Holding Ltd Ordinary Shares |
-2.73% |
5.65% |
* Contemporary Amperex Technology Co Ltd Class A |
-- |
5.03% |
* LONGi Green Energy Technology Co Ltd Class A |
-- |
3.81% |
* WuXi Biologics (Cayman) Inc |
-23.92% |
3.45% |
* Wuxi Lead Intelligent Equipment Co Ltd Class A |
-- |
3.42% |
* NARI Technology Co Ltd Class A |
-- |
2.87% |
* Meituan Class B |
-28.46% |
2.76% |
* Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A |
-- |
2.73% |
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|